TransMedics [TMDX] vs Stryker [SYK] Detailed Stock Comparison

TransMedics Group Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: TransMedics Group Inc. wins in 4 metrics, Stryker Corporation wins in 16 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric TransMedics Group Inc. Stryker Corporation Better
P/E Ratio (TTM) 23.29 39.21 TransMedics Group Inc.
Price-to-Book Ratio 8.22 5.62 Stryker Corporation
Debt-to-Equity Ratio 109.76 72.97 Stryker Corporation
PEG Ratio 0.02 0.72 TransMedics Group Inc.
EV/EBITDA 28.01 19.90 Stryker Corporation
Profit Margin (TTM) 31.43% 12.92% TransMedics Group Inc.
Operating Margin (TTM) 13.23% 27.24% Stryker Corporation
EBITDA Margin (TTM) 13.23% 27.24% Stryker Corporation
Return on Equity 54.24% 15.08% TransMedics Group Inc.
Return on Assets (TTM) 7.25% 7.92% Stryker Corporation
Free Cash Flow (TTM) $133.59M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return -48.97% -17.25% Stryker Corporation
Price-to-Sales Ratio (TTM) 6.47 5.02 Stryker Corporation
Enterprise Value $3.77B $138.30B Stryker Corporation
EV/Revenue Ratio 6.22 5.51 Stryker Corporation
Gross Profit Margin (TTM) 58.11% 64.54% Stryker Corporation
Revenue per Share (TTM) $18 $66 Stryker Corporation
Earnings per Share (Diluted) $4.87 $8.40 Stryker Corporation
Beta (Stock Volatility) 2.08 0.93 Stryker Corporation
Short % of Float 36.27% 1.20% Stryker Corporation

TransMedics Group Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

TMDX
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TransMedics Group Inc.3.52%6.10%19.43%-39.47%-38.71%-38.48%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TransMedics Group Inc.-48.97%-7.27%144.83%193.99%193.99%193.99%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: TransMedics Group Inc. vs Stryker Corporation

MetricTMDXSYK
Market Information
Market Cap i$3.91B$126.25B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i666,2071,881,406
90 Day Avg. Volume i896,7592,161,139
Last Close$75.48$307.94
52 Week Range$60.10 - $156.00$281.00 - $404.87
% from 52W High-51.62%-23.94%
All-Time High$177.37 (Aug 19, 2024)$406.19 (Jan 27, 2025)
% from All-Time High-57.44%-24.19%
Growth Metrics
Quarterly Revenue Growth0.32%0.11%
Quarterly Earnings Growth14.37%0.56%
Financial Health
Profit Margin (TTM) i0.31%0.13%
Operating Margin (TTM) i0.13%0.27%
Return on Equity (TTM) i0.54%0.15%
Debt to Equity (MRQ) i109.7672.97
Cash & Liquidity
Book Value per Share (MRQ)$13.81$58.61
Cash per Share (MRQ)$14.24$10.71
Operating Cash Flow (TTM) i$192.84M$5.04B
Levered Free Cash Flow (TTM) i$94.00M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: TransMedics Group Inc. vs Stryker Corporation

MetricTMDX (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i23.2939.21
Forward P/E i30.8019.67
PEG Ratio i0.020.72
Price to Sales (TTM) i6.475.02
Price to Book (MRQ) i8.225.62
Market Capitalization
Market Capitalization i$3.91B$126.25B
Enterprise Value i$3.77B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i6.225.51
Enterprise to EBITDA i28.0119.90
Risk & Other Metrics
Beta i2.080.93
Book Value per Share (MRQ) i$13.81$58.61

Financial Statements Comparison: TransMedics Group Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTMDX (2025)SYK (2025)
Revenue/Sales i605.49M25.12B
Cost of Goods Sold i242.69M9.05B
COGS % of Revenue i40.1%36.0%
Gross Profit i362.81M16.07B
Gross Margin i59.9%64.0%
Research & Development i69.06M1.62B
Operating Income (EBIT) i108.58M5.06B
Operating Margin i17.9%20.1%
EBITDA i148.49M6.48B
EBITDA Margin i24.5%25.8%
Pre-Tax Income i107.52M4.51B
Pre-Tax Income % of Revenue i17.8%18.0%
Income Tax i-82.77M1.27B
Income Tax % of Revenue i-13.7%5.0%
Net Income (Profit) i190.29M3.25B
Profit Margin i31.4%12.9%

Balance Sheet & Liquidity Metrics

MetricTMDX (2025)SYK (2025)
Cash & Equivalents i488.37M4.01B
Total Current Assets i637.78M14.76B
Total Current Assets % of Revenue i105.3%58.7%
Total Current Liabilities i89.31M7.79B
Total Current Liabilities % of Revenue i14.7%31.0%
Long-Term Debt i505.97M14.86B
Long-Term Debt % of Revenue i83.6%59.2%
Total Shareholders Equity i473.10M22.42B
Retained Earnings i-277.95M20.47B
Retained Earnings % of Revenue i-45.9%81.5%
Property, Plant & Equipment i45.54M1.79B

Cash Flow Statement Comparison

MetricTMDX (2025)SYK (2025)
Operating Cash Flow i180.45M4.70B
Operating Cash Flow % of Revenue i29.8%18.7%
Capital Expenditures i-59.25M-761.00M
Free Cash Flow i133.59M4.28B
FCF Margin i22.1%17.1%
Debt Repayment iN/A-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTMDXSYK
Shares Short i8.03M4.42M
Short Ratio i7.661.95
Short % of Float i36.27%1.20%
Shares Outstanding i34.27M382.50M
Float Shares i33.19M346.55M
% Held by Insiders i3.30%5.37%
% Held by Institutions i110.68%82.09%
% Held by Public i-13.98%12.54%

Dividend Analysis & Yield Comparison: TransMedics Group Inc. vs Stryker Corporation

MetricTMDXSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025